BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6875846)

  • 1. Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments.
    Johnson JD; Fugman DA
    J Pharmacol Exp Ther; 1983 Aug; 226(2):330-4. PubMed ID: 6875846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of various calmodulin antagonists on contraction of rabbit aortic strips.
    Asano M; Suzuki Y; Hidaka H
    J Pharmacol Exp Ther; 1982 Jan; 220(1):191-6. PubMed ID: 7053415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous assessment of effects of calmodulin antagonists and Ca++ channel blockers on the electrophysiological and mechanical characteristics in excised guinea-pig papillary muscles.
    Koyama K; Himori N
    Arch Int Pharmacodyn Ther; 1988; 292():141-56. PubMed ID: 3395166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide and other calmodulin antagonists (calmodulin interacting agents) on calcium-induced contraction of rabbit aortic strips.
    Kanamori M; Naka M; Asano M; Hidaka H
    J Pharmacol Exp Ther; 1981 May; 217(2):494-9. PubMed ID: 6453220
    [No Abstract]   [Full Text] [Related]  

  • 5. Ca2+-bound calmodulin forms a compact globular structure on binding four trifluoperazine molecules in solution.
    Matsushima N; Hayashi N; Jinbo Y; Izumi Y
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):211-5. PubMed ID: 10727421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors.
    Cooper CL; Malik KU
    J Pharmacol Exp Ther; 1984 Apr; 229(1):139-47. PubMed ID: 6423810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), a calmodulin antagonist in arterial strips from rats and rabbits.
    Asano M; Hidaka H
    J Pharmacol Exp Ther; 1985 Aug; 234(2):476-84. PubMed ID: 4020681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of calcium antagonists and vasodilators on arterial myosin phosphorylation and actin-myosin interactions.
    Silver PJ; Dachiw J; Ambrose JM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):141-8. PubMed ID: 6747823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calcium-antagonist and calmodulin-antagonist drugs on calmodulin-dependent contractions of chemically skinned vascular smooth muscle from rabbit renal arteries.
    Kreye VA; Rüegg JC; Hofmann F
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(2):85-9. PubMed ID: 6888571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperativity among calmodulin's drug binding sites.
    Mills JS; Bailey BL; Johnson JD
    Biochemistry; 1985 Aug; 24(18):4897-902. PubMed ID: 4074665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists affect calmodulin-dependent contractility of a skinned smooth muscle.
    Metzger H; Stern HO; Pfitzer G; Rüegg JC
    Arzneimittelforschung; 1982; 32(11):1425-7. PubMed ID: 6891247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of felodipine with calcium-binding proteins.
    Johnson JD; Andrews CT; Khabbaza EJ; Mills JS
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S53-9. PubMed ID: 2442519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin antagonists' binding sites on calmodulin.
    Tanaka T; Ohmura T; Hidaka H
    Pharmacology; 1983; 26(5):249-57. PubMed ID: 6304789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM; Cysouw KJ; Verdouw PD
    Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effects of calmodulin antagonists on the endothelium-dependent relaxation in rabbit aorta.
    Nagase H; Karaki H; Urakawa N
    Nihon Heikatsukin Gakkai Zasshi; 1986 Apr; 22(2):97-102. PubMed ID: 3099043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin, Ca2+-antagonists and Ca2+-transporters in nerve and muscle.
    Johnson JD; Wittenauer LA; Nathan RD
    J Neural Transm Suppl; 1983; 18():97-111. PubMed ID: 6308155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric interactions among drug binding sites on calmodulin.
    Johnson JD
    Biochem Biophys Res Commun; 1983 Apr; 112(2):787-93. PubMed ID: 6847674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.